Versant Venture Management, LLC
Versant Venture Management, LLC reported 8 holdings worth US$163M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 12, 2026
Versant Venture Management, LLC reported 8 holdings worth US$163M as of Jun 30, 2026. Largest: Monte Rosa Therapeutics, Inc., Century Therapeutics, Inc. and Jade Biosciences, Inc. Filed Aug 12, 2026 (Form 13F).
- Holdings
- 8
- Value as reported
- US$163M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 3.18M | US$77M | 47.3% |
| Century Therapeutics, Inc. | 12.2M | US$29.8M | 18.3% |
| Jade Biosciences, Inc. | 992K | US$22M | 13.6% |
| Lenz Therapeutics, Inc. | 2.66M | US$15.1M | 9.3% |
| Contineum Therapeutics, Inc. | 543K | US$8.89M | 5.5% |
| Skye Bioscience, Inc. | 2.01M | US$1.39M | 0.86% |